AzTrials
AzTrials

Postoperative ComplicationsNCT06563583

Comparison of the Effectiveness of Air-Q SP Among Different Age Groups

An observational study of Postoperative Complications and Sore-throat, run by Diskapi Yildirim Beyazit Education and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Some previous studies have reported structural and physiological changes in the pharyngeal airway and UES with aging . It has been found that the shape and size of the pharyngeal airway in elderly individuals differ from those of young adults. Read more about this study

Who is it for?
Ages 18 to 85 years
What is being tested?
Group 1 will include patients aged 18-40 years, Group 2 will include patients aged 40-64 years and Group 3 will include patients aged 65-85 years
How many people
153 participants
Where
1 siteTurkey (Türkiye)
Study dates
2 Sep 2024to 30 Mar 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients undergoing elective surgery under general anesthesia with the use of an SP Air-Q.

Who may be able to join

  • 18-85 year-old patients
  • American Society of Anesthesiologist Physical Status classification I-III,
  • Undergoing an elective operation under general anesthesia in our hospital

Who cannot join

  • Predicted difficult airway (Mallampati class 4, mouth opening < 3 cm, or thyromental distance < 6 cm)
  • body mass index (BMI) > 40 kg/m2
  • Patients with a high risk of aspiration (e.g., history of gastrectomy, gastroesophageal reflux disease, or hiatal hernia),
  • Unstable vital signs,
  • Cervical spine problems, Respiratory complications (e.g. recent pneumonia).

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Zeynep Koç

    Yenimahalle, Ankara

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of the Effectiveness of Self-Pressurizing Air-Q Intubating Laryngeal Airways Among Different Age Groups

Some previous studies have reported structural and physiological changes in the pharyngeal airway and UES with aging . It has been found that the shape and size of the pharyngeal airway in elderly individuals differ from those of young adults. This study aims to compare the effectiveness of the Air-Q laryngeal mask airway (LMA) across different age groups (young, middle-aged, and elderly patients) and to evaluate complications associated with supraglottic airways (SGA).

Read the detailed description

"Supraglottic airway devices (SGA) used perioperatively are known to require lower anesthetic depth and result in fewer airway complications such as coughing and sore throat after awakening from anesthesia compared to endotracheal intubation. Due to these advantages, SGAs are particularly beneficial in elderly patients, as they experience a reduction in functional reserves, are more affected by cardiopulmonary diseases, and are more sensitive to anesthetic drugs

SGAs are inserted through the oral route, and the SGA cuff is placed between the base of the tongue, hypopharynx, and upper esophageal sphincter (UES) to provide proper ventilation. Some previous studies have reported structural and physiological changes in the pharyngeal airway and UES with aging . It has been found that the shape and size of the pharyngeal airway in elderly individuals differ from those of young adults. Additionally, there are changes in the function and structure of the UES with age. These age-related changes may affect the performance of SGAs in the elderly population.

Recently, SGAs that do not require manual cuff inflation have been used more frequently in various clinical settings due to the advantages of eliminating the need for manual cuff inflation and cuff pressure monitoring. The Air-Q is connected to an airway tube through a communication port that allows for self-regulation of cuff pressure in response to airway pressure."

Being tested
Group 1 will include patients aged 18-40 years, Group 2 will include patients aged 40-64 years, Group 3 will include patients aged 65-85 years
Keywords
Air-Q SP İntubating Laryngeal Airway, oropharyngeal leak pressure, supraglottic airways
Medical subject headings
Postoperative Complications, Pharyngitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Group 1 will include patients aged 18-40 yearsOther

    Group 1 will include patients aged 18-40 years.

  • Group 2 will include patients aged 40-64 yearsOther

    Group 2 will include patients aged 40-64 years, and finally.

  • Group 3 will include patients aged 65-85 yearsOther

    Group 3 will include patients aged 65-85 years.

Study groups in NCT06563583
Study groupRoleWhat they receive
Group 1Group 1 will include patients aged 18-40 years.
Receives: Other: Group 1 will include patients aged 18-40 years
Group 2Group 2 will include patients aged 40-64 years.
Receives: Other: Group 2 will include patients aged 40-64 years
Group 3Group 3 will include patients aged 65-85 years.
Receives: Other: Group 3 will include patients aged 65-85 years

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurement of oropharyngeal leak pressure (OLP)

    One minute after successful LMA placement and fixation, oropharyngeal leak pressure (OLP) will be measured by setting the adjustable pressure limiting valve (APL) to 40 mmHg and maintaining a fresh gas flow of 3 L/min. The OLP will be recorded as the pressure at which an audible leak sound is heard from the mouth.

    Measured: One minute after successful LMA placement

Secondary outcomes (7)
  1. SP Air-Q insertion time

    Successful LMA placement will be confirmed by visualizing a square waveform on the ventilator and observing chest wall movement.

    Measured: 3 minutes after induction of anesthesia

  2. ease of LMA placement

    The ease of LMA placement will be scored by the anesthesiologist on a scale from 1 to 4 (1: Successful on the first attempt with no resistance from the tissues; 2: Successful on the first attempt but with some tissue resistance during placement; 3: Moderate tissue resistance; 4: Failure to place the LMA).

    Measured: 3 minutes after induction of anesthesia

  3. maneuvers required for successful ventilation

    It will be recorded whether any further maneuvers are required: Gentle pushing or pulling of the LMA to adjust its depth, jaw-thrust maneuver, and flexion or extension of the head.

    Measured: 3 minutes after induction of anesthesia

  4. fiberoptic view grading

    The Brimacombe score will be used to evaluate the view obtained with fiberoptic bronchoscopy. 1: Vocal cords are not visible; 2: Vocal cords and anterior epiglottis are visible; 3: Vocal cords and posterior epiglottis are visible; 4: Vocal cords are visible.

    Measured: 3 minutes after induction of anesthesia

  5. Complications during SP_Air-Q removal (emerge)

    such as breath-holding during emergence, airway obstruction, coughing, hypoxia (SpO2 < 90%), vomiting, lip-tongue-teeth trauma, and bleeding, will be recorded

    Measured: One minute after SP Air-Q removal

  6. sore throat

    Postoperative complication

    Measured: 1-24 hours postoperatively

  7. dysphonia

    Postoperative complication

    Measured: 1-24 hours postpoeratively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2024
  2. Study start2 Sep 2024
  3. Primary completion7 Nov 2024
  4. Study completion30 Mar 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
153 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06563583
Sponsor's protocol ID
ZeynepKoc001
Status last verified
Aug 2025
First submitted
19 Aug 2024
Last updated
19 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Lee JS, Kim DH, Choi SH, Ha SH, Kim S, Kim MS. Prospective, Randomized Comparison of the i-gel and the Self-Pressurized air-Q Intubating Laryngeal Airway in Elderly Anesthetized Patients. Anesth Analg. 2020 Feb;130(2):480-487. doi: 10.1213/ANE.0000000000003849.

    PubMed 30320644
  • Kim EM, Kim MS, Koo BN, Lee JR, Lee YS, Lee JH. Clinical efficacy of the classic laryngeal mask airway in elderly patients: a comparison with young adult patients. Korean J Anesthesiol. 2015 Dec;68(6):568-74. doi: 10.4097/kjae.2015.68.6.568. Epub 2015 Nov 25.

    PubMed 26634080
  • Kim MH, Lee JH, Choi YS, Park S, Shin S. Comparison of the laryngeal mask airway supreme and the i-gel in paralysed elderly patients: A randomised controlled trial. Eur J Anaesthesiol. 2018 Aug;35(8):598-604. doi: 10.1097/EJA.0000000000000700.

    PubMed 28857785

Questions about this trial

What is this clinical trial studying?

An observational study of Postoperative Complications and Sore-throat, run by Diskapi Yildirim Beyazit Education and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurement of oropharyngeal leak pressure (OLP) (time frame: One minute after successful LMA placement). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06563583, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in